While GLUT1 and GLUT3 expression could be considered as useful potential biomarkers for tumor behavior in laryngeal cancer, discrepancies exist for other tumors of this region due to variation of tumor types, histological differentiation status, and proliferative index, which cause differences in their biology. The gene discussed is SLC2A3; the disease is laryngeal carcinoma.